These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1404 related articles for article (PubMed ID: 32234451)

  • 1. COVID-19, SARS and MERS: are they closely related?
    Petrosillo N; Viceconte G; Ergonul O; Ippolito G; Petersen E
    Clin Microbiol Infect; 2020 Jun; 26(6):729-734. PubMed ID: 32234451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
    Elrashdy F; Redwan EM; Uversky VN
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
    Quan C; Li C; Ma H; Li Y; Zhang H
    Clin Microbiol Rev; 2020 Oct; 34(1):. PubMed ID: 33055229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
    Asrani P; Hasan GM; Sohal SS; Hassan MI
    OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2).
    Masood N; Malik SS; Raja MN; Mubarik S; Yu C
    Front Cell Infect Microbiol; 2020; 10():499. PubMed ID: 32974224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
    Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
    Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
    Wang Y; Wang Y; Chen Y; Qin Q
    J Med Virol; 2020 Jun; 92(6):568-576. PubMed ID: 32134116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
    Abdelrahman Z; Li M; Wang X
    Front Immunol; 2020; 11():552909. PubMed ID: 33013925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
    Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
    APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
    Meo SA; Alhowikan AM; Al-Khlaiwi T; Meo IM; Halepoto DM; Iqbal M; Usmani AM; Hajjar W; Ahmed N
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2012-2019. PubMed ID: 32141570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2?
    Monroy-Gómez J; Torres-Fernández O
    Biomedica; 2020 Oct; 40(Supl. 2):173-179. PubMed ID: 33152201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to SARS, MERS, and COVID-19 from animal health perspective.
    Gautam A; Kaphle K; Shrestha B; Phuyal S
    Open Vet J; 2020 Aug; 10(2):164-177. PubMed ID: 32821661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
    Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
    Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus Disease 2019: Coronaviruses and Kidney Injury.
    Lv W; Wu M; Ren Y; Zeng N; Deng P; Zeng H; Zhang Q; Wu Y
    J Urol; 2020 Nov; 204(5):918-925. PubMed ID: 32693711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.
    Zhu Z; Lian X; Su X; Wu W; Marraro GA; Zeng Y
    Respir Res; 2020 Aug; 21(1):224. PubMed ID: 32854739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.